A Prediction Model of Preeclampsia in Hyperglycemia Pregnancy
Yan Fang,Huali Liu,Yuan Li,Ji Cheng,Xia Wang,Bing Shen,Hongbo Chen,Qunhua Wang
DOI: https://doi.org/10.2147/dmso.s453204
2024-03-18
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Yan Fang, 1, 2 Huali Liu, 1, 2 Yuan Li, 1, 2 Ji Cheng, 1 Xia Wang, 1 Bing Shen, 3 Hongbo Chen, 1, 2 Qunhua Wang 4 1 Department of Obstetrics and Gynaecology, Maternal and Child Health Hospital Affiliated to Anhui Medical University, Hefei, People's Republic of China; 2 The Fifth Clinical College of Anhui Medical University, Hefei, People's Republic of China; 3 School of Basic Medicine, Anhui Medical University, Hefei, People's Republic of China; 4 Department of Obstetrics and Gynaecology, the First Affiliated Hospital of USTC, Hefei, People's Republic of China Correspondence: Hongbo Chen, Maternal and Child Health Hospital Affiliated to Anhui Medical University, No. 15 Yimin Street, Luyang District, Hefei City, Anhui Province, People's Republic of China, Email Qunhua Wang, Department of Obstetrics and Gynaecology, the First Affiliated Hospital of USTC, Hefei, People's Republic of China, Email Purpose: To investigate the risk factors associated with preeclampsia in hyperglycemic pregnancies and develop a predictive model based on routine pregnancy care. Patients and Methods: The retrospective collection of clinical data was performed on 951 pregnant women with hyperglycemia, including those diagnosed with diabetes in pregnancy (DIP) and gestational diabetes mellitus (GDM), who delivered after 34 weeks of gestation at the Maternal and Child Health Hospital Affiliated to Anhui Medical University between January 2017 and December 2019. Observation indicators included liver and kidney function factors testing at 24– 29 +6 weeks gestation, maternal age, and basal blood pressure. The indicators were screened univariately, and the "rms" package in R language was applied to explore the factors associated with PE in HIP pregnancy by stepwise regression. Multivariable logistic regression analysis was used to develop the prediction model. Based on the above results, a nomogram was constructed to predict the risk of PE occurrence in pregnant women with HIP. Then, the model was evaluated from three aspects: discrimination, calibration, and clinical utility. The internal validation was performed using the bootstrap procedure. Results: Multivariate logistic regression analysis showed that cystatin C, uric acid, glutamyl aminotransferase, blood urea nitrogen, and basal systolic blood pressure as predictors of PE in pregnancy with HIP. The predictive model yielded an area under curve (AUC) value of 0.8031 (95% CI: 0.7383– 0.8679), with an optimal threshold of 0.0805, at which point the sensitivity was 0.8307 and specificity of 0.6604. Hosmer–Lemeshow test values were P = 0.3736, Brier score value was 0.0461. After 1000 Bootstrap re-samplings for internal validation, the AUC was 0.7886, the Brier score was 0.0478 and the predicted probability of the calibration curve was similar to the actual probability. A nomogram was constructed based on the above to visualize the model. Conclusion: This study developed a model for predicting PE in pregnant women with HIP, achieving high predictive performance of PE risk through the information of routine pregnancy care. Keywords: hyperglycemia in pregnancy, preeclampsia, prediction model, nomogram, internal validation The International Federation of Obstetrics and Gynaecology (FIGO) defined "hyperglycemia in pregnancy" (HIP) as hyperglycemia covering all severity levels, which can be divided into DIP (either preexisting diabetes—type 1 or type 2—which antedates pregnancy or is first identified during testing in the index pregnancy) and GDM. 1 According to the latest (10th) edition of the International Diabetes Federation's Diabetes Map 2021, approximately 16.7% of women of childbearing age worldwide experience varying degrees of elevated blood glucose during pregnancy. 2 HIP is associated with a significantly increased risk of adverse perinatal outcomes, including preeclampsia, birth injuries, increased caesarean section rates, and an increased incidence of type 2 diabetes mellitus in offspring. 3–5 The International Society for the Study of Hypertension in Pregnancy (ISSHP) defines PE as new onset hypertension and proteinuria after 20 weeks of gestation or with other end-organ damage, that affects 2–8% of pregnancies worldwide, and can lead to preterm delivery, fetal growth restriction, maternal convulsions, damage to vital organs such as the heart, liver and kidneys and in severe cases, maternal and fetal death. 6–8 It has been shown that HIP is associated with an increased risk of PE. 9 Some studies have shown that mechanisms related to glucose metabolism are involved in th -Abstract Truncated-
endocrinology & metabolism